STOCK TITAN

CRWV Form 144: 32,455 shares via Morgan Stanley, sale on 10/08/2025

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CoreWeave (CRWV) Form 144 reports proposed sale of 32,455 common shares through Morgan Stanley Smith Barney with an aggregate market value of $4,181,177.65, listed for an approximate sale date of 10/08/2025 on NASDAQ. The filing shows the shares were originally acquired on 02/23/2020 as Series A preferred stock conversion. Recent activity in the past three months includes multiple Rule 10b5-1 sales by Michael Intrator and Omnadora Capital LLC totaling several transactions: notable sales on 10/07/2025, 09/30/2025, 09/24/2025, 09/10/2025, and 08/27/2025, with individual gross proceeds shown per trade. The filer certifies no undisclosed material adverse information and references reliance on Rule 10b5-1 trading plans where applicable.

Positive

  • Transparent disclosure of proposed sale and past 10b5-1 sales with gross proceeds listed
  • Use of Rule 10b5-1 plans for several transactions indicates pre‑planned, compliant selling

Negative

  • Multiple recent insider sales produced multi‑million dollar proceeds, increasing share supply in short term
  • Proposed sale of 32,455 shares (~$4.18M) adds to recent dispositions by insiders and affiliates

Insights

Insiders and affiliated entities have conducted multiple planned sales, including a new 144 for 32,455 shares (~$4.18M).

The filing shows the 32,455-share proposed sale via Morgan Stanley and lists the acquisition origin as a Series A preferred stock conversion on 02/23/2020. This is a routine disclosure when insiders or affiliates intend to sell restricted or converted shares.

Key dependencies include whether sales are part of existing 10b5-1 plans; the past three months show several 10b5-1 sales by Michael Intrator and Omnadora Capital LLC, producing multi-million-dollar proceeds. Watch short-term trading cadence around 10/08/2025 for any incremental supply pressure.

Aggregate recent insider sales total tens of millions, which may modestly increase available float near sale dates.

Reported gross proceeds per recent trades range from roughly $3.10M to $10.95M, indicating repeated sizeable dispositions rather than single small disposals. The 32,455-share filing adds $4.18M of potential selling into the market.

Market effect depends on trading volume and liquidity on NASDAQ; if daily volume is low, clustered insider sales could create temporary downward pressure. Monitor reported settlement and any cancellations or amendments in the days after 10/08/2025.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed for CoreWeave (CRWV) disclose?

The filing discloses a proposed sale of 32,455 common shares via Morgan Stanley with an aggregate market value of $4,181,177.65, targeted for 10/08/2025 on NASDAQ.

Who conducted recent sales disclosed in the filing for CRWV?

Recent sales include Rule 10b5-1 transactions by Michael Intrator and Omnadora Capital LLC on dates including 10/07/2025, 09/30/2025, 09/24/2025, 09/10/2025, and 08/27/2025.

How were the 32,455 shares acquired according to the Form 144?

The securities were acquired on 02/23/2020 through a Series A preferred stock transaction and show an acquisition amount of 32,455 shares.

Does the filing indicate reliance on a 10b5-1 trading plan?

Yes; multiple entries are labeled as 10b5-1 sales, and the filer’s signature block includes the representation tied to 10b5-1 plan adoption or instruction dates.

What gross proceeds were reported for recent insider sales?

Recent gross proceeds per trade range from about $3.10M to $10.95M, with individual line items such as $8,130,425.59 and $10,952,733.12 shown.